About Sixfold Bioscience
Sixfold Bioscience is a company based in London (United Kingdom) founded in 2017. Sixfold Bioscience has raised $4.59 million across 7 funding rounds from investors including European Union, Cantos Ventures and Y Combinator. The company has 16 employees as of December 31, 2021. Sixfold Bioscience offers products and services including Mergo Platform. Sixfold Bioscience operates in a competitive market with competitors including Insulet, Lyra Therapeutics, Candel Therapeutics, StrideBio and TriSalus Life Sciences, among others.
- Headquarter London, United Kingdom
- Employees 16 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sixfold Bioscience Inc.
- Date of Incorporation 08 Oct, 2018
- Jurisdiction WALNUT, CALIFORNIA 91789, UNITED STATES
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.59 M (USD)
in 7 rounds
-
Latest Funding Round
$2.2 M (USD), Seed
Dec 02, 2021
-
Investors
European Union
& 4 more
-
Employee Count
16
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sixfold Bioscience
Sixfold Bioscience offers a comprehensive portfolio of products and services, including Mergo Platform.
AI-enhanced platform for RNA therapy delivery solutions.
People of Sixfold Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Sixfold Bioscience
Sixfold Bioscience has successfully raised a total of $4.59M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $2.2 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sixfold Bioscience
Sixfold Bioscience has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Cantos Ventures and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed stage tech-focused VC firm investing primarily in the US
|
Locked | Locked | Locked | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
Early-stage AI startups are funded and supported by Pi Campus.
|
Locked | Locked | Locked |
Investor details for Sixfold Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sixfold Bioscience
Investment portfolio details for Sixfold Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sixfold Bioscience
Detailed financials for Sixfold Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sixfold Bioscience Comparisons
Peer comparison for Sixfold Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sixfold Bioscience
Sixfold Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insulet, Lyra Therapeutics, Candel Therapeutics, StrideBio and TriSalus Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for ENT diseases are developed.
|
|
| Locked | Locked | Locked |
Viral immunotherapies are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
AAV-based gene therapies for rare diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of drug delivery devices to treat cancers
|
|
| Locked | Locked | Locked |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
Detailed competitors of Sixfold Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sixfold Bioscience
Complete news archive for Sixfold Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sixfold Bioscience
Sixfold Bioscience was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Sixfold Bioscience is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Sixfold Bioscience is a funded company, having raised a total of $4.59M across 7 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Sixfold Bioscience is 16.
Sixfold Bioscience was founded in 2017 in London, United Kingdom. Operations are centered in the biotechnology sector, where oligonucleotide delivery systems are developed. The Mergo platform is employed to target gene therapy molecules to diseased cells. In vivo delivery methods for RNA therapeutics are supported by this technology, enabling precise administration in therapeutic applications.
Sixfold Bioscience's top competitors include Insulet, Lyra Therapeutics and TriSalus Life Sciences.
Sixfold Bioscience offers Mergo Platform.
Sixfold Bioscience has 5 investors. Key investors include European Union, Cantos Ventures, Y Combinator, Pi Campus, and Lombardstreet Ventures.